Wednesday, June 17, 2026

Policy

Policy•Fierce Biotech•Jun 16, 2026

Eli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4E

background ▾

• •Eli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4E

→ Read original article

Policy•Fierce Biotech•Jun 16, 2026

How Biogen is transforming its pipeline with a VC mindset and an ‘entrepreneurial spirit’

background ▾

• •How Biogen is transforming its pipeline with a VC mindset and an ‘entrepreneurial spirit’

→ Read original article

Policy•Fierce Biotech•Jun 16, 2026

Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling

background ▾

• •Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling

→ Read original article

Policy•STAT News•Jun 16, 2026

The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations

background ▾

• •The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations

→ Read original article

Policy•Fierce Biotech•Jun 16, 2026

PE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M

background ▾

• •PE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M

→ Read original article

Market Access

No articles for this category on this date.

Clinical Trials

No articles for this category on this date.